← back to search

Katherine E. Harris

Chrono Therapeutics (United States) · US
Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research interests include Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Blood Pressure and Hypertension Studies, and Glycosylation and Glycoproteins Research.
h-index
26
citations
2,929
works
57
NIH funding
primary concept
Medicine
email

Recent publications

<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors
Journal of Clinical Oncology 2021cited by 164position: middledoi
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release
Journal for ImmunoTherapy of Cancer 2021cited by 68position: middledoi
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies
mAbs 2019cited by 100position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2019–2021)Kevin Dang · Barrow Neurological Institute2 papers (2019–2021)Duy Pham · University of Queensland2 papers (2019–2021)Andrew Boudreau · Amgen (United States)2 papers (2019–2021)Suhasini Iyer · Gene Therapy Laboratory2 papers (2019–2021)Ben Buelow · University of San Francisco2 papers (2019–2021)Wim van Schooten · University of South Carolina2 papers (2019–2021) · 2 papers (2019–2021) · 2 papers (2019–2021)Starlynn Clarke · Chrono Therapeutics (United States)2 papers (2019–2021)Harshad S. Ugamraj · Amgen (United States)2 papers (2019–2021)Serena S. Kwek · University of San Francisco1 papers (2021–2021)Priya Choudhry · California Institute of Technology1 papers (2019–2019)Yuping Li · Neurological Surgery1 papers (2021–2021)David J. Kwiatkowski · Harvard University1 papers (2021–2021)Wenchao Sun · Palo Alto University1 papers (2021–2021)Shihe Hou · Gansu Agricultural University1 papers (2021–2021)Neil Desai · Medtronic (Ireland)1 papers (2021–2021)Anita N. Schmid · C3I (United States)1 papers (2021–2021)Andrew J. Wagner · Dana-Farber Cancer Institute1 papers (2021–2021)